ID: h-e7e1f943
Hypothesis

Microbial Inflammasome Priming Prevention

Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-inflammatory state that enhances neuroinflammation and dopaminergic neuron vulnerability.
🧬 NLRP3, CASP1, IL1B, PYCARD🩺 neurodegeneration🎯 Composite 65%💱 $0.66▼15.9%proposed
EvidencePending (0%)📖 47 cit🗣 2 debates 5 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.80 (15%) Evidence 0.90 (15%) Novelty 0.70 (12%) Feasibility 0.80 (12%) Impact 0.80 (12%) Druggability 0.90 (10%) Safety 0.60 (8%) Competition 0.80 (6%) Data Avail. 0.80 (5%) Reproducible 0.70 (5%) KG Connect 0.33 (8%) 0.653 composite

🧪 Overview

Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-inflammatory state that enhances neuroinflammation and dopaminergic neuron vulnerability. Selective inflammasome inhibitors combined with microbiome restoration could break this inflammatory cycle.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

graph TD
    A["Microbial PAMPs<br/>LPS and Bacterial Components"] --> B["TLR4 and PRR<br/>Pattern Recognition"]
    B -->|"Signal 1"| C["NF-kappaB Nuclear<br/>Translocation"]
    C --> D["Pro-IL1B and Pro-IL18<br/>Transcription"]
    
    E["ATP and Danger Signals<br/>Extracellular"] -->|"Signal 2"| F["P2X7 Receptor<br/>Activation"]
    F --> G["Potassium Efflux<br/>and ROS Generation"]
    G --> H["NLRP3 Protein<br/>Conformational Change"]
    
    D --> I["Cytoplasmic Pro-IL1B<br/>Accumulation"]
    H --> J["PYCARD ASC Adapter<br/>Recruitment"]
    J --> K["Pro-CASP1<br/>Oligomerization"]
    K --> L["Active Caspase-1<br/>Formation"]
    
    I --> L
    L -->|"Proteolytic Cleavage"| M["Mature IL1B<br/>Release"]
    L --> N["Gasdermin D<br/>Pore Formation"]
    
    M --> O["Neuroinflammatory<br/>Cascade Activation"]
    N --> P["Pyroptotic Cell Death<br/>and DAMP Release"]
    P --> Q["Microglial Activation<br/>and Proliferation"]
    Q --> R["Synaptic Dysfunction<br/>and Neurodegeneration"]
    
    S["NLRP3 Inhibitors<br/>MCC950 Treatment"] -->|"Therapeutic Block"| H
    T["Caspase-1 Inhibitors<br/>VX-765 Compounds"] --> L
    U["IL1B Antagonists<br/>Anakinra Therapy"] --> O
    
    O --> R
    
    classDef normal fill:#4fc3f7,stroke:#2196f3,color:#0d0d1a
    classDef therapeutic fill:#81c784,stroke:#4caf50,color:#0d0d1a
    classDef pathology fill:#ef5350,stroke:#f44336,color:#0d0d1a
    classDef outcome fill:#ffd54f,stroke:#ff9800,color:#0d0d1a
    classDef molecular fill:#ce93d8,stroke:#9c27b0,color:#0d0d1a
    
    class A,B,E,F normal
    class H,J,K,L,I,M,N molecular
    class O,Q,P pathology
    class R outcome
    class S,T,U therapeutic
    class C,D,G normal

⚖️ Evidence

⚖️ Evidence Matrix5 supports3 contradicts
Supports
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.
Cell Mol Immunol2025PMID:40075143medium
Supports
Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.
Cell Rep Med2024PMID:38701781medium
Supports
NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.
Proc Natl Acad Sci U S A2021PMID:34497121medium
Supports
Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption.
J Neuroinflammation2023PMID:36859349medium
Supports
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition.
Front Immunol2021PMID:34367186medium
Contradicts
MCC950/NLRP3 inhibition has strong preclinical rationale but translational pharmacology and safety limitations remain unresolved for chronic neurodegenerative use.
Pharmacol Rev2021PMID:34117094medium
Contradicts
A Parkinson NLRP3 inhibitor study focused on anti-inflammatory biomarker effects rather than demonstrated disease modification, leaving the clinical impact of inflammasome blockade uncertain.
Mov Disord2025PMID:40792655medium
Contradicts
Gut-inflammasome links are framed as axis-level physiology and pathology, but do not prove that bacterial inflammasome priming is the dominant driver of dopaminergic vulnerability.
Front Immunol2020PMID:33362788medium
📖 Linked Papers (30)Export BibTeX ↗
Fig. 1
Fig. 1
Dynamic microglial activation programs and signaling networks in Alzheimer’s disease (AD). Under physiological conditions, microglia exist in a state of homeost...
Fig. 2
Fig. 2
Schematic representation of astrocytic activation and neuroinflammatory pathways in Alzheimer’s disease (AD). Exposure to amyloid-β (Aβ) or injury triggers reac...
Figures
Figures
Figures available at source paper (no open-access XML found).
Figure 1
Figure 1
2D cross-sectional OCT images of the four case biofilms evaluated. The scale bars indicate 100 µm.
Figure 2
Figure 2
Influence of the OCT focus point on the signal intensity distribution across a 2D cross-sectional image of a homogeneous agar layer. OCT images represent the cr...
Figure 1
Figure 1
( a ) TEM image of the MoS 2 flake decorated with GQDs. ( b ) TEM image of the GQDs on the MoS 2 . ( c ) HR-TEM image of the GQDs on the few-layer MoS 2 . ( d ...
Figure 2
Figure 2
Schematic diagram of the sandwiched MIM device. ( a ) Reference device and ( b ) tristable switching device. ( c ) SEM cross-sectional structure characterizatio...
Sepsis and the Liver.
Diseases (Basel, Switzerland) (2025) · PubMed:41439929 ↗
No figures
📙 Related Wiki Pages (15)

🏥 Translation

🧬 3D Protein Structure — NLRP3

🧬 PDB 7PZC Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for NLRP3, CASP1, IL1B, PYCARD from GTEx v10.

Spinal cord cervical c-12.7 Cortex2.4 Frontal Cortex BA92.2 Nucleus accumbens basal ganglia1.9 Hypothalamus1.7 Anterior cingulate cortex BA241.6 Substantia nigra1.6 Hippocampus1.4 Amygdala1.3 Caudate basal ganglia1.0median TPM (GTEx v10)

💉 Clinical Trials (3)Relevance: 4%

0
Active
0
Completed
0
Total Enrolled
Unknown·NCT03808389
Unknown·NCT03671785
Unknown·NCT02269150

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NLRP3, CASP1, IL1B, PYCARD →

No DepMap CRISPR Chronos data found for NLRP3, CASP1, IL1B, PYCARD.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
18 months

🏆 Tournament

🏆 Arenas / Elo

Elo Rating
1250 ±141
Record
3W / 7L / 0D
10 matches

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 2.9%
Volatility
High
0.0573
Events (7d)
4
Price History
▼15.9%

💾 Resource Usage

LLM Tokens
34,972
$0.2158
Total Cost
$0.2158

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If hypothesis is true, intervention be instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processesbe instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processes— no observation —pending0.90
If hypothesis is true, intervention leverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetranceleverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetrance— no observation —pending0.90
🔮 Falsifiable Predictions (2)
pendingconf 90%
If hypothesis is true, intervention leverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetrance
Predicted outcome: leverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetrance
Falsification: Intervention fails to leverage liposomal encapsulation and targeted nanoparticle technologies to enhance compound bioavailability and cerebral penetrance
pendingconf 90%
If hypothesis is true, intervention be instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processes
Predicted outcome: be instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processes
Falsification: Intervention fails to be instrumental in comprehensively understanding the complex interactions underlying neuroinflammatory processes
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.